SCM
ALXN

Sio Capital Management’s Alexion Pharmaceuticals ALXN Stock Holding History

Sio Capital Management’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-37,781
Closed -$4.09M – 107
2019
Q4 		$4.09M Sell
37,781
-13,500
-26% -$1.44M 1.24% 28
2019
Q3 		$5.02M Sell
51,281
-20,240
-28% -$2.28M 1.79% 23
2019
Q2 		$9.37M Buy
71,521
+36,100
+102% +$4.65M 2.88% 11
2019
Q1 		$4.79M Buy
35,421
+18,421
+108% +$2.29M 1.46% 28
2018
Q4 		$1.66M Sell
17,000
-8,785
-34% -$1.04M 0.64% 52
2018
Q3 		$3.58M Buy
+25,785
New +$3.23M 1.53% 30

Other funds holding ALXN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $431B AUM 30.22% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return